{"id":953,"date":"2021-02-25T17:38:20","date_gmt":"2021-02-25T20:38:20","guid":{"rendered":"https:\/\/www.vitapharmaconsulting.com\/en\/?post_type=noticias&#038;p=953"},"modified":"2022-04-26T17:43:57","modified_gmt":"2022-04-26T20:43:57","slug":"anvisa-update-of-the-guideline-20-2019-on-topical-and-transdermal-products","status":"publish","type":"noticias","link":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/02\/25\/anvisa-update-of-the-guideline-20-2019-on-topical-and-transdermal-products\/","title":{"rendered":"ANVISA &#8211; Update of the Guideline 20\/2019 on topical and transdermal products"},"content":{"rendered":"<p>ANVISA published the second version of Guideline 20\/2019, which provides guidance on quality requirements for topical and transdermal products.<\/p>\n<p>This guideline was published in 2018 and it was open for contributions for one year, resulting the new version published on ANVISA\u2019s website. The current version improved some textual topics in this document and its scope is no longer restricted to Marketing Authorization, extending also to the entire product life cycle.<\/p>\n<p>Regarding to quality aspects, we can highlight the following topics:<\/p>\n<p>Inclusion of the available dose uniformity test, as well as the concept of non-applicability for the uniformity test in the packaging material for fluid topical products that need to be stirred before use.<\/p>\n<p>Complement of the requirements for receiving medium used in performance tests and membrane used in permeation tests.<\/p>\n<p>Access the complete Guideline throught the link: https:\/\/bit.ly\/3pR15dA<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"author":1,"featured_media":956,"template":"","meta":{"inline_featured_image":false,"_links_to":"","_links_to_target":""},"categorias":[22],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v20.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>ANVISA - Update of the Guideline 20\/2019 on topical and transdermal products - Vita<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/02\/25\/anvisa-update-of-the-guideline-20-2019-on-topical-and-transdermal-products\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ANVISA - Update of the Guideline 20\/2019 on topical and transdermal products - Vita\" \/>\n<meta property=\"og:description\" content=\"ANVISA published the second version of Guideline 20\/2019, which provides guidance on quality requirements for topical and transdermal products. This guideline was published in 2018 and it was open for contributions for one year, resulting the new version published on ANVISA\u2019s website. The current version improved some textual topics in this document and its scope... Leia mais &raquo;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/02\/25\/anvisa-update-of-the-guideline-20-2019-on-topical-and-transdermal-products\/\" \/>\n<meta property=\"og:site_name\" content=\"Vita\" \/>\n<meta property=\"article:modified_time\" content=\"2022-04-26T20:43:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.vitapharmaconsulting.com\/en\/wp-content\/uploads\/2022\/04\/a2b6198cf950ab88bed116e57ea2c98e-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"2667\" \/>\n\t<meta property=\"og:image:height\" content=\"1500\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/02\/25\/anvisa-update-of-the-guideline-20-2019-on-topical-and-transdermal-products\/\",\"url\":\"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/02\/25\/anvisa-update-of-the-guideline-20-2019-on-topical-and-transdermal-products\/\",\"name\":\"ANVISA - Update of the Guideline 20\/2019 on topical and transdermal products - Vita\",\"isPartOf\":{\"@id\":\"https:\/\/www.vitapharmaconsulting.com\/en\/#website\"},\"datePublished\":\"2021-02-25T20:38:20+00:00\",\"dateModified\":\"2022-04-26T20:43:57+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/02\/25\/anvisa-update-of-the-guideline-20-2019-on-topical-and-transdermal-products\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/02\/25\/anvisa-update-of-the-guideline-20-2019-on-topical-and-transdermal-products\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/02\/25\/anvisa-update-of-the-guideline-20-2019-on-topical-and-transdermal-products\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Not\u00edcias\",\"item\":\"https:\/\/www.vitapharmaconsulting.com\/en\/news\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ANVISA &#8211; Update of the Guideline 20\/2019 on topical and transdermal products\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.vitapharmaconsulting.com\/en\/#website\",\"url\":\"https:\/\/www.vitapharmaconsulting.com\/en\/\",\"name\":\"Vita\",\"description\":\"Regulatory affairs &amp; consulting\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.vitapharmaconsulting.com\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"pt-BR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ANVISA - Update of the Guideline 20\/2019 on topical and transdermal products - Vita","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/02\/25\/anvisa-update-of-the-guideline-20-2019-on-topical-and-transdermal-products\/","og_locale":"pt_BR","og_type":"article","og_title":"ANVISA - Update of the Guideline 20\/2019 on topical and transdermal products - Vita","og_description":"ANVISA published the second version of Guideline 20\/2019, which provides guidance on quality requirements for topical and transdermal products. This guideline was published in 2018 and it was open for contributions for one year, resulting the new version published on ANVISA\u2019s website. The current version improved some textual topics in this document and its scope... Leia mais &raquo;","og_url":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/02\/25\/anvisa-update-of-the-guideline-20-2019-on-topical-and-transdermal-products\/","og_site_name":"Vita","article_modified_time":"2022-04-26T20:43:57+00:00","og_image":[{"width":2667,"height":1500,"url":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-content\/uploads\/2022\/04\/a2b6198cf950ab88bed116e57ea2c98e-1.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. tempo de leitura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/02\/25\/anvisa-update-of-the-guideline-20-2019-on-topical-and-transdermal-products\/","url":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/02\/25\/anvisa-update-of-the-guideline-20-2019-on-topical-and-transdermal-products\/","name":"ANVISA - Update of the Guideline 20\/2019 on topical and transdermal products - Vita","isPartOf":{"@id":"https:\/\/www.vitapharmaconsulting.com\/en\/#website"},"datePublished":"2021-02-25T20:38:20+00:00","dateModified":"2022-04-26T20:43:57+00:00","breadcrumb":{"@id":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/02\/25\/anvisa-update-of-the-guideline-20-2019-on-topical-and-transdermal-products\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/02\/25\/anvisa-update-of-the-guideline-20-2019-on-topical-and-transdermal-products\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/02\/25\/anvisa-update-of-the-guideline-20-2019-on-topical-and-transdermal-products\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Not\u00edcias","item":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/"},{"@type":"ListItem","position":2,"name":"ANVISA &#8211; Update of the Guideline 20\/2019 on topical and transdermal products"}]},{"@type":"WebSite","@id":"https:\/\/www.vitapharmaconsulting.com\/en\/#website","url":"https:\/\/www.vitapharmaconsulting.com\/en\/","name":"Vita","description":"Regulatory affairs &amp; consulting","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.vitapharmaconsulting.com\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"pt-BR"}]}},"_links":{"self":[{"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/noticias\/953"}],"collection":[{"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/noticias"}],"about":[{"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/types\/noticias"}],"author":[{"embeddable":true,"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/users\/1"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/media\/956"}],"wp:attachment":[{"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/media?parent=953"}],"wp:term":[{"taxonomy":"categorias","embeddable":true,"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/categorias?post=953"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}